Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Suh Kyungbae Science Foundation holds the first symposium 2020-11-12 08:00
I-Mab Announces Preclinical Data on Differentiated Anti-C5aR Antibody TJ210/MOR210 at SITC 2020 2020-11-11 21:00
Innovation Drives Excellence, Innovent Successfully Held 2020 Virtual R&D Day 2020-11-11 08:00
FibroGenesis Announces the Filing of its 250th Patent for Fibroblast Cell Therapy Platform 2020-11-10 22:37
Bioheng Announced Oral Presentation of Its Preliminary Results of CRISPR-Engineered Allogeneic CAR-T for r/r B-ALL Treatment at 2020 ASH Meeting 2020-11-10 22:30
I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting 2020-11-09 21:12
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update 2020-11-09 21:00
GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit 2020-11-09 20:30
TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R) 2020-11-09 18:22
Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim 2020-11-09 18:07
Semaglutide 2.4 mg injection demonstrated significant weight loss versus placebo when added to intensive behavioural therapy 2020-11-06 01:50
PolyActiva successfully completes initial clinical trial with Latanoprost FA SR Ocular Implant delivering glaucoma treatment to patients over a six-month period 2020-11-05 21:00
Gracell Biotechnologies Announces Two Oral Presentations at the ASH Annual Meeting and Exposition 2020 2020-11-05 11:52
Cellarity signs up with Excelra for GOSTAR database to enrich its drug discovery platform 2020-11-05 10:00
Samsung Biologics' Virtual Exhibition Hall earns top industry award for digital creativity and innovation 2020-11-04 20:00
Nel ASA: Selected by Iberdrola as preferred supplier for a 20 MW green fertilizer project in Spain 2020-11-04 03:35
Great Bay Bio Announces Its First AI-enabled Bioprocessing Platform-Klone 4.0, Reducing Cell Line Development Time and Cost by Up to 80% 2020-11-02 22:00
Senhwa Announces Multiple IND application submissions to U.S. FDA for Silmitasertib as a Potential Treatment for COVID-19 2020-11-02 22:00
RevImmune advances new immunotherapy in COVID-19 2020-11-02 21:00
CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates 2020-11-02 19:00
1 271 272 273 274 275 451